In a Form S-3, Ardea Biosciences (Nasdaq: RDEA) announced that it plans to resell from time to time of up ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE